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Abstract
Small interfering RNAs (siRNAs) are routinely used to reduce mRNA levels for a specific gene with the goal of studying its
function. Several studies have demonstrated that siRNAs are not always specific and can have many off-target effects. The 39
UTRs of off-target mRNAs are often enriched in sequences that are complementary to the seed-region of the siRNA. We
demonstrate that siRNA off-targets can be significantly reduced when cells are treated with a dose of siRNA that is relatively
low (e.g. 1 nM), but sufficient to effectively silence the intended target. The reduction in off-targets was demonstrated for
both modified and unmodified siRNAs that targeted either STAT3 or hexokinase II. Low concentrations reduced silencing of
transcripts with complementarity to the seed region of the siRNA. Similarly, off-targets that were not complementary to the
siRNA were reduced at lower doses, including up-regulated genes that are involved in immune response. Importantly, the
unintended induction of caspase activity following treatment with a siRNA that targeted hexokinase II was also shown to be
a concentration-dependent off-target effect. We conclude that off-targets and their related phenotypic effects can be
reduced for certain siRNA that potently silence their intended target at low concentrations.
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Introduction
RNA interference (RNAi) is a natural gene silencing process
employed by both plants and animals. Laboratory methods using
the mechanism have been devised to allow for knockdown of the
mRNA levels of nearly any gene of interest. The technology is
commonly employed in gene-specific and genome-wide functional
assays [1] and offers the potential to develop a novel class of
therapeutics [2]. Two of the major types of RNAi include small
interfering RNA (siRNA) and microRNA (miRNA) [3].
In mammals, siRNA are typically 21 nucleotides in length and
consist of a guide strand and a complementary passenger strand.
The siRNA is bound by the RNA-induced silencing complex
(RISC), which facilitates the cleavage and/or degradation of
mRNA that are complementary to the guide strand [4]. These
short double-stranded RNA molecules are typically produced by
the Dicer enzyme, which cleaves both exogenous and endogenous
double stranded RNA [5,6,7]. However, Dicer-mediated process-
ing can be bypassed by transfecting mammalian cells with ,21
nucleotide double-stranded RNA. The duplex typically consists of
19 complementary nucleotides with 2- nucleotide overhangs at the
39 end.
miRNA are non-coding RNA genes that are expressed in both
plants and animals. The initial transcripts go through various
processing steps, including the generation of ,80 nucleotide stem
loop pre-miRNA and Dicer cleavage to produce a mature 22
nucleotide double stranded RNA [8,9,10,11]. The mature miRNA
is bound by the RISC complex, which in turn, binds to the
39UTRs of mRNAs and results in mRNA degradation and/or
translation repression. In miRNA, the seed region that typically
spans nucleotides 2-7 is complementary to the 39UTR target sites
and is primarily responsible for translation repression [12]. The
rest of the guide strand is partially complementary to the 39UTR
and appears to be less important for mRNA silencing.
Clearly, there are a number of similarities between the miRNA
pathway and the siRNA pathway. Indeed, siRNAs can function as
miRNAs [13,14] and several studies have shown that siRNA can
regulate unintended transcripts via seed complementarity in their
39UTRs [7,15,16,17,18,19]. Such off-targets can produce false
positives in siRNA screens [20] and have the potential to cause
undesired side effects in a clinical trial. The human transcriptome
contains thousands of 39UTR stretches that are complementary to
any given seed region, and it is difficult to determine which of
these seed-matches are capable of being bona fide miRNA-like off-
targets. While seed accessibility is clearly an important parameter
for miRNA-like binding [21,22], we have not succeeded in using
accessibility-based methods to accurately predict miRNA off-
targets in human cells. Encouragingly, a recent study demonstrat-
ed that it is possible to reduce miRNA-like off-targets by
introducing a 29-O-methyl ribosyl substitution at position 2 of
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the passenger strand can eliminate the immunostimulatory effects
that are sometimes associated with siRNA [24,25].
In theory, the partial base-pairing between a siRNA and a
39UTR is expected to be less thermodynamically stable than a full-
length siRNA-mRNA duplex. We therefore hypothesized that
siRNA with high affinity for their intended target could be used at
a minimum effective dose such that miRNA-like off-targets would
be significantly reduced or eliminated. We tested this hypothesis
with both modified and unmodified siRNA and the results are
described below.
Results
Potent siRNA
To study off-target effects, we designed siRNAs that targeted
hexokinase II (HK2) and STAT3 and had minimal complemen-
tarity with other transcripts encoded by the human genome
(Table 1, see Materials and Methods). To determine whether a
minimum effective dose could reduce miRNA-like off-targets, it
was important to use potent siRNA. Using RT-PCR, both
STAT3-1676 and HK2-3581 were shown to reduce mRNA levels
of their respective targets by 50% or more at 1 nM (Figure 1A).
Both STAT3-1676M and HK2-3581-M, which contain a 29-O-
methyl modification at position 2, also silenced their respective
targets at levels that were similar to the unmodified siRNA
(Figure 1B). Therefore, these siRNA were considered sufficiently
potent to test our hypothesis.
Definition of off-targets
To assess off-targets, cells were treated with each siRNA at
1 nM, 10 nM, and 25 nM and compared to non-targeting control
siRNA using Affymetrix microarrays. Off-targets were defined as
transcripts with a 2-fold change in mRNA level (RMA normalized
values) and a P-value less than or equal to 0.05 at any dose. This
definition of off-targets allows for the inclusion of both up-
regulated and down-regulated transcripts that are not necessarily
bound by the siRNA/RISC complex.
Off-targets for unmodified siRNA are reduced at
minimum effective doses
Using the above definition of off-targets, we observed a total of
174 off-targets (2 fold change at any dose) when MCF-7 cells were
treated with STAT3-1676. Off-targets for STAT3-1676
(Figures 2A and S1) are described in detail below.
At 25 nM, there were 38 off-targets that were down-regulated
more than STAT3 (Figure 2A, S1, and Table 2). Consistent with
previous findings, the majority of these down-regulated off-targets
possess a stretch of 39UTR that is complementary to the seed
region (32/56). In contrast, the majority of the up-regulated off-
targets do not possess a 39UTR region that is complementary to
siRNA seed region. Interestingly, 9 of the genes with at least a 2-
fold increase in expression were annotated as immune response
genes (Table S1). The set of up-regulated off-targets was
significantly enriched in the ‘immune response’ GO term when
compared to all other genes in the genome (P=1.6e-13, Table S2).
Decreasing the siRNA concentration from 25 nM to 10 nM did
not have a significant effect on STAT3 silencing (Figure 2A, S1,
and Table 2), but the number of off-targets was reduced such that
only 1 gene (DDR1) was down-regulated more than STAT3. The
number of off-targets with a 2-fold decrease in mRNA levels was
decreased from 56 transcripts (25 nM) to 30 transcripts (10 nM).
Again, the majority of these down-regulated off-targets (22/30)
have a site in their 39UTR that is 100% complementary to the
seed region of the siRNA. The immune response genes continued
to be up-regulated.
When the siRNA concentration was reduced to 1 nM, there
was still a more than 2-fold decrease in STAT3 mRNA levels,
which was not significantly different than the levels observed at the
higher siRNA doses (Figure 2A, S1, and Table 2). Importantly,
STAT3 was the most significantly knocked-down transcript at
1 nM and none of the off-targets that were observed at the higher
doses were down-regulated by two-fold or more. Indeed, there
were only 6 off-targets with more than a 1.6-fold decrease in
mRNA levels at 1 nM, whereas there were 67 off-targets with this
level of down-regulation at 25 nM. All of the immune response
genes that were up-regulated at the higher doses were reduced to a
1.6 fold change or less at 1 nM, suggesting that the apparent
immune response was independent of STAT3 silencing.
For HK2-3581, we observed 1169 off-targets that were
significantly up- or down-regulated at one or more doses in
Hep3B cells. Off-targets for HK2-3581 (Figures 2B and S2) are
described in detail below.
At 25 nM, we observed a 4.2 fold decrease in HK2 mRNA
levels and there were 77 off-targets that were silenced at greater
levels than HK2 (Figure 2B, S2, and Table 2). Of the 728 off-
targets that exhibited more than a 2-fold decrease in mRNA levels,
288 possess a stretch of 39UTR that is complementary to the seed
region. In contrast, only 4 of the 430 off-targets with a 2-fold
increase in mRNA levels have a 39UTR that is complementary to
the seed region of the siRNA. Interestingly, the majority of off-
targets that were annotated as being involved in immune response
were down-regulated (Table S3).
When the concentration of HK2-3581 was reduced from
25 nM to 10 nM, there was a 3.3 fold decrease in HK2 mRNA
levels compared to the 4.2 fold decrease observed at 25 nM
Table 1. siRNA sequences used in this study.
siRNA Guide strand Passenger strand
AllStars negative control UUUGUAAUCGUCGAUACCC GGGUAUCGACGAUUACAAA
HK2-3581/HK2-3581M UUGUUGUGCAUCUCCACUCuu GAGUGGAGAUGCACAACAAuu
HK2-4031 UCCAUGUUCACACACAUCCuu GGAUGUGUGUGAACAUGGAuu
PLK1 Pool Pool
siGenome2 non-targeting control GUAUCUCUUCAUAGCCUUA UAAGGCUAUGAAGAGAUAC
STAT3-1676/STAT3-1676M UUGGUCAGCAUGUUGUACCuu GGUACAACAUGCUGACCAAuu
The canonical seed region, positions 2–7, is underlined in the guide strand. 39 overhangs are in lowercase. The modified (M) versions are identical in sequence to the
unmodified siRNA and contain a 29-O-methyl ribosyl substitution at position 2 of the guide strand.
doi:10.1371/journal.pone.0021503.t001
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concentration had a greater effect on the number of off-targets.
The number of off-targets that were down-regulated more strongly
than HK2 was reduced from 77 to 1. Nevertheless, there were still
42 off-targets with a 2-fold decrease in mRNA levels and 24 of
these had a 39UTR that was complementary to the seed region.
Furthermore, there were 89 off-targets with a 2-fold increase in
mRNA levels at 10 nM.
When the siRNA concentration was reduced to 1 nM, there
was a 2.1-fold decrease in HK2 mRNA levels compared to the 3.3-
fold decrease observed at 10 nM (Figure 2B, S2, and Table 2), but
HK2 was the most potently down-regulated gene and all of the off-
targets that were observed at the higher concentrations exhibited
less than a 2-fold decrease in mRNA levels. Interestingly, there
were still 41 off-targets with a 2-fold increase in mRNA levels at
1 nM.
Taken together, the above results demonstrate that it is possible
to identify a minimum effective dose for certain siRNA, such that
potential off-targets are significantly reduced. At these lower doses,
the intended targets were the most potently down-regulated genes.
For STAT3, the lower dose did not significantly decrease the level
of silencing. Although a decrease in HK2 silencing was observed at
1 nM, there was still a 2-fold decrease in mRNA levels.
Importantly, our qPCR experiments demonstrated that mRNA
levels for both STAT3 and HK2 were decreased by more than
60% at the lower 1 nM concentration (Figure 1).
Furthermore, off-targets that lacked seed complementarity or
were annotated as being involved in immune response were also
significantly reduced at the lowest dose.
Modified siRNA have fewer off-targets at minimum
effective doses
Previous studies have demonstrated that off-targets can be
reduced by including a 29-O-methyl ribosyl substitution at position
2 of the guide strand [23]. To confirm these observations and to
determine whether off-targets could be further reduced at
minimum effective doses, we incorporated this modification into
STAT3-1676-M and HK2-3581-M (Table 1). In q-PCR exper-
iments, both STAT3-1676M and HK2-3581M were shown to
silence their respective targets at levels that were similar to their
unmodified versions (Figure 1).
Figure 2. Off-targets for unmodified siRNA. A) Cells were
transfected with the specified doses of STAT3-1676. B) Cells were
transfected with the specified doses of HK2-3581. The greatest changes
in off-target transcript levels were observed at the higher concentra-
tions. The intended target was the most significantly down-regulated
transcript at 1 nM.
doi:10.1371/journal.pone.0021503.g002
Figure 1. siRNAs potently silence their intended targets. RT-PCR
of purified RNA demonstrated that all concentrations of siRNA reduced
mRNA levels of the intended targets by 50% or more relative to control.
A) STAT3-1676 and STAT3-1676M. B) HK2-3581 and HK2-3581M.
doi:10.1371/journal.pone.0021503.g001
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we detected 325 off-targets for STAT3-1676M that were either up
or down-regulated (Figures 3A and S3). Surprisingly, this was
significantly more than the 174 off-targets observed for the
unmodified STAT3-1676 and demonstrates that this particular
modification does not always reduce the number of off-targets.
The differences between STAT3-1676M and STAT3-1676 were
primarily observed at the highest concentration (Table 2) and are
further described below.
At 25 nM, there was a 3.8 fold decrease in STAT3 mRNA
levels, which was more than the 2.2 fold decrease observed for the
unmodified STAT3-1676. This difference is probably due to
biological or experimental variation as the unmodified siRNA was
slightly more potent in the qPCR experiments. Due to the
relatively potent silencing of STAT3 by STAT3-1676M, there
were only 5 off-targets that were down-regulated more than
STAT3 (Figures 3A, S3, and Table 2). However, there were 102
off-targets with a 2-fold decrease in mRNA levels and 65 of these
off-targets possess a 39UTR that is complementary to the seed
region of STAT3-1676M. In contrast, the same concentration of
unmodified STAT3-1676 caused a 2-fold decrease in 56 off-targets
where 32 of them were complementary to the seed region in their
39UTRs. There were 219 off-targets with a two-fold increase in
expression compared to 54 off-targets observed for the unmodified
STAT3-1676. Similar to the unmodified siRNA, there were 9 off-
targets with a two-fold increase in expression that were also
annotated as being involved in immune response.
When the concentration of STAT3-1676M was decreased from
25 nM to 10 nM, there was no change in the level of STAT3
silencing (Figure 3A, S3, and Table 2). However, the number of
down-regulated off-targets was significantly decreased at 10 nM
and was slightly less than the number observed for unmodified
STAT3-1676 at the same concentration. The majority of off-
targets (20/23) that were down-regulated 2-fold or more have a
39UTR that is complementary to the seed region of STAT3-
1676M. The number of off-targets that were up-regulated by two-
fold or more was reduced to 30 genes compared to the 63 genes
observed for the unmodified STAT3-1676. Only 2 genes from this
set of these up-regulated off-targets are annotated as being
involved in immune response.
Reducing the concentrations of STAT3-1676M from 10 nM to
1 nM did not significantly alter STAT3 silencing but did reduce
off-targets further (Figure 3A, S3, and Table 2). There was only
one off-target that was down-regulated by two-fold or more and
STAT3 was clearly the most down-regulated gene. Similar to the
unmodified STAT3-1676, there were no off-targets that were up-
regulated by two-fold or more and the up-regulation of genes
involved in immune response was mitigated.
For HK2-3581M, there were 270 off-targets (up or down-
regulated) detected at one or more doses, which was significantly
less than the 1169 off-targets observed for the unmodified HK2-
3581M (Figures 3B and S4).
At 25 nM, 66 off-targets were down-regulated at greater levels
than HK2 which was slightly fewer than the 77 off-targets down-
regulated at greater levels than HK2 in response to the unmodified
HK2-3581 (Figure 3B, S4, and Table 2). However, the number of
off-targets that were down-regulated 2-fold or more was
considerably fewer for HK2-3581M (202 off-targets) than for
HK2-3581 (728 off-targets). Consistent with this, the number of
off-targets with seed-complementarity to the 39UTR was also less
for HK2-3581M (73 off-targets) than for HK2-3581 (288 off-
targets). The number of off-targets that were up-regulated by two-
fold or more was also reduced for HK2-3581M (67 off-targets)
relative to HK2-3581 (430 off-targets).
Despite the ability of the 29-O-methyl ribosyl modification to
significantly reduce off-targets, it was clear that modification of this
particular siRNA was not sufficient to eliminate all off-targets at
this dose.
Reducing the dose of HK2-3581M from 25 nM to 10 nM
dramatically reduced the number of off-targets without having an
effect on HK2 silencing (Figures 3B, S4, and Table 2). There was a
2.6-fold silencing of HK2 and none of the off-targets were down-
regulated more than the intended target. Whereas unmodified
HK2-3581 altered the expression of several genes by two-fold or
more, HK2-3581M did not induce a two-fold expression of any
off-targets at 10 nM.
When the concentration of HK2-3581M was reduced from
10 nM to 1 nM, silencing of HK2 was decreased from 2.6 fold to
1.47 fold (Figure 3B, S4, and Table 2). Indeed, one off-target
(DSG2) was down-regulated slightly more (1.5-fold decrease) than
Table 2. Summary of off-targets.
siRNA Log2FC target Q . target 2-fold Q (seed) 2-fold q(seed)
STAT3-1676 (25 nM) 22.2 38 56(32) 54(7)
STAT3-1676 (10 nM) 22.7 1 30(22) 63(11)
STAT3-1676 (1 nM) 22.3 0 0(0) 0(0)
STAT3-1676M (25 nM) 23.8 5 102(65) 219(48)
STAT3-1676M (10 nM) 23.8 1 23(20) 30(6)
STAT3-1676M (1 nM) 23.7 0 1(1) 0(0)
HK2-3581 (25 nM) 24.2 77 728(288) 430(4)
HK2-3581 (10 nM) 23.3 1 42(24) 89(0)
HK2-3581 (1 nM) 22.1 0 0(0) 41(0)
HK2-3581M (25 nM) 22.5 66 202(73) 67(6)
HK2-3581M (10 nM) 22.6 0 0(0) 0(0)
HK2-3581M (1 nM) 21.47 1 0(0) 0(0)
The table shows the log2 fold change for the intended target, the number of transcripts that are down-regulated more than the intended target (Q .target), the
number of transcripts that are down-regulated 2-fold or more along with the subset that are complementary to seed region 2–7 (2-fold Q (seed)), and the number of
transcripts that are up-regulated by 2-fold or more along with the subset that are complementary to seed region 2–7 ((2-fold q (seed)).
doi:10.1371/journal.pone.0021503.t002
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were down or up-regulated by two-fold or more, compared to
unmodified HK2-3581, which induced a two-fold increase in
expression of 41 genes at the same concentration. As HK2
silencing was also reduced at 1 nM, the optimal dose is probably
between 1 nM and 10 nM.
The above results confirm that 29-O-methyl ribosyl modifica-
tions can effectively reduce off-targets for some but not all siRNA,
and demonstrate that the reduction in off-targets can extend
beyond 39UTRs that are complementary to the seed region.
Importantly, we demonstrate that a low effective dose can
significantly reduce off-targets that still exist for a modified siRNA
at higher doses.
39UTR off-targets
To further evaluate the role of seed complementarity in the
39UTR of off-targets at different concentrations, we analyzed each
microarray experiment with an implementation of the Sylamer
method [26]. Using a series of fold-change cut-off levels,
corresponding 39UTRs were grouped as being above or below
each fold-change threshold. For each grouping, hypergeometric
tests were performed to determine whether one set of 39UTRs
were significantly over or under-represented in a particular k-mer
(4
k possible k-mers) relative to the other set of 39UTRs. As an
exhaustive analysis of all k-mers is performed, we can determine if
a k-mer of interest is over or under-represented relative to all other
control k-mers. The analysis was performed for both hexamers
and heptamers at all concentrations (Figures S5-12) and
concentrations where heptamers are particularly enriched in the
39UTRs of off-targets are shown in Figure 4.
Although we previously observed more off-targets with seed
complementarity in their 39UTRs at 25 nM than the lower
concentrations (Table 2 and Figures S1-4), enrichment of off-
targets with seed complementarity was generally more striking at
10 nM than 25 nM (Figures S5–12). This is because off-targets
that are not complementary to the seed region were also increased
at 25 nM.
Clearly, off-targets for both STAT3-1676 and STAT3-1676M
were over-represented in 39UTRs that are complementary to the
seed regions of the siRNA (Figure 4A and 4B). Among the initial
cut-offs, where down-regulated transcripts were compared to other
transcripts, the most significantly enriched heptamers (CUGA-
CCA and UGACCAA) are complementary to seed region 2–8 and
1–7 of the siRNA respectively. The passenger strands for STAT3-
1676 and STAT3-1676M did not have a major effect on mRNA
levels, as the P-values for the complementary heptamers (UGUU-
GUA, GUUGUAC, and UUGUACC) were among background
P-values. Similarly, heptamers that are complementary to the seed
region of the passenger and guide strands of the non-targeting
control were among background P-values. For example, hepta-
mers that are complementary to positions 1–7 of the passenger and
guide strands (AGCCUUA and GAGAUAC) are among back-
ground P-values (Figure 4A and 4B).
Figure 4C shows that down-regulated off-targets for HK2-
3581(25 nM) were over-represented in 39UTR heptamers that are
complementary to the seed region. In particular, the down-
regulated off-targets had 39UTRs that were enriched in the
heptamer ACAACAA, which is complementary to seed region 1–
7. For HK2-3581M, the heptamers (ACAACAA and CA-
CAACA), which are complementary to seed regions 1–7 and 2–
8, were the most over-represented heptamers among down-
regulated transcripts (Figure 4D). The passenger strands for HK2-
3581 and HK2-3581M did not have a major impact on mRNA
levels as the complementary heptamers (UCUCCAC, CUC-
CACU, UCCACUC) were among background P-values. Again,
heptamers that are complementary to positions 1–7 of the non-
targeting control (passenger and guide strands) were among
background P-values for down-regulated transcripts.
Recently, the U-rich motifs URM1 (UUUUAAA) and URM2
(UUUGUUU) which are bound by the ELAV4 RNA binding
protein [27] were shown to be enriched in the 39UTRS of
transcripts down-regulated by miRNA and siRNA [28]. For both
HK2-3581 and HK2-3581-M, URM1 is among the most enriched
heptamers at various fold-change cut-off levels (Figure 4C-D, S10
and S12).
For STAT3-1676-M (Figure 4B and S8), URM1 is under-
represented at the higher concentrations, particularly among the
up-regulated transcripts. This under-representation among up-
regulated transcripts was unexpected and may indicate that the
non-targeting control siRNA tends to bind 39UTRs that contain
URM1. For the unmodified STAT3-1676 (Figure 4A and S6),
URM1 is among the over-represented heptamers found in
39UTRs that belong to down-regulated transcripts that were
Figure 3. Off-targets for modified siRNA. A) Cells were transfected
with the specified doses of STAT3-1676M. B) Cells were transfected with
the specified doses of HK2-3581M. The greatest changes in off-target
transcript levels were observed at the higher concentrations. STAT3 was
the most significantly down-regulated transcript at 1 nM. HK2 was the
most significantly down-regulated transcript at10 nM.
doi:10.1371/journal.pone.0021503.g003
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under-represented among any of the off-targets that were detected
in response to our siRNA (Figures 4, S6, S8, S10, and S12).
Indeed, the URM2 motif was among the background P-values that
were observed for the control heptamers. Although the URM1
and URM2 motifs were previously shown to be over-represented
in the 39UTRs of down-regulated transcripts, the results for our
siRNA were less conclusive.
Collectively, the above experiments demonstrated that down-
regulated off-targets are enriched in 39UTRs that are comple-
mentary to seed region of both modified siRNA and unmodified
siRNA. The 29-O-methyl ribosyl modification at position 2 of the
guide strand is designed to make seed-39UTR interactions less
favorable and does indeed reduce the number of off-targets for
HK2 (Table 2). Nevertheless, the k-mer enrichment analysis
demonstrates that seed-39UTR complementarity can still be an
issue for modified siRNA, particularly at higher doses.
HK2-3581 induces caspase activity
As described above, we observed 1155 off-targets for HK2-
3581, suggesting a potential for significant phenotypic effects at
higher doses. The majority of down-regulated off-targets possessed
39UTRs that were not complementary to the seed region (Table 2).
Up-regulated transcripts for HK2-3581 were significantly enriched
in GO terms relating to cell cycle and a slightly less striking
enrichment was also observed for HK2-3581M (Tables S4–S7).
Furthermore, visual inspection of the cells following treatment
with HK2-3581, suggested that the cells were undergoing
apoptosis. To confirm this, we compared HK2-3581 to HK2-
4031 in caspase activation and cell proliferation assays. We chose
Figure 4. 39UTR heptamer enrichment analysis for each siRNA. A) Enrichment of 39UTRS with seed complementarity to STAT3-1676 was most
striking at 10 nM. B) Enrichment of 39UTRS with seed complementary to STAT3-1676M was most striking at 10 nM. C) Enrichment of 39UTRS with
seed complementary to HK2-3581 was most striking at 25 nM. D) Enrichment of 39UTRS with seed complementary to HK2-3581M was most striking at
10 nM. Transcripts from each microarray were rank-ordered by log2 fold-change and P-values were computed at different levels of fold-change
(increments of 100). The hyper-geometric test was used to assess whether a particular heptamer was over or under-represented in 39UTRs at each
level of fold-change.
doi:10.1371/journal.pone.0021503.g004
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and consistent with our previous findings, its off-targets were also
reduced at a lower concentration (Figure S13).
Treatment of Hep3B cells with HK2-3581, led to moderate
induction of caspase activity at 25 nM (Figure 5A). In contrast, the
chemically modified HK2-3581M and HK2-4031 did not induce
caspase activity. The same HK2-targeting siRNA did not inhibit
cell proliferation relative to a PLK1 siRNA positive control
(Figure 5B).
As HK2-4031 did not induce caspase activation, we conclude
that caspase activation is independent of HK2 silencing and is
most likely due to HK2-3581 off-targets. Indeed, the reduced
number of off-targets observed for the lower doses of HK2-3581
(Table 2) was consistent with caspase activation being observed
only at the higher dose.
Although the precise mechanism for caspase activation was not
determined, we observed two off-targets, BNIP3L and BIRC3,
which were significantly down-regulated at higher concentrations
(Figures S2-4) and have been previously implicated in apoptosis.
BIRC3 (cIAP2) binds to caspase-7 and caspase-3 and protects cells
from apoptosis when it is over-expressed [29]. However, BIRC3 is
probably not a direct miRNA-like off-target, as its 39UTR does not
have a region that is complementary to the seed of HK2-3581.
BNIP3L (BNIP3a, Nix) has been implicated in both positive and
negative regulation of apoptosis [30,31]. As BNIP3L has a 39UTR
that is complementary to the seed of HK2-3581, it is possible that
it is a direct miRNA-like off-target.
In summary, the above experiments demonstrate that siRNA
off-targets have the potential to cause phenotypic effects at
higher doses. The lack of caspase activity observed at the lower
doses emphasizes the importance of using the lowest effective
dose.
Discussion
It is now well established that siRNA off-targets exist for many
siRNA and that most siRNA molecules are probably not as
specific as once thought [32,33]. Although there are a variety of
ways in which off-targets might be induced, miRNA-like binding
in the 39UTR has been proposed as one of the major causes of
siRNA off-targets [15,17]. Consistent with these findings,
chemical modification of nucleotides in the seed region of a
siRNA can significantly reduce off-targets that are complemen-
tary to the seed in the 39UTR [7,15,16,17,18,19]. However, it is
also clear that siRNA off-targets can induce detectable pheno-
typic effects that may or may not be a direct result of 39UTR
binding [20,34,35].
This study revealed four key findings that we expect to be
applicable to a particular subset of siRNA molecules that potently
silence their intended target:
1) Reducing the concentration of a siRNA to a low effective
dose where the intended target is still potently silenced can
lead to a significant reduction in the number of off-targets
that undergo significant changes in expression. This finding
was observed for 3 different siRNA duplexes that potently
silenced either STAT3 or HK2 (Figures 2-3 and S13). The
reduction in off-targets not only applied to transcripts that
possessed complementary 39UTRs but also included other
off-targets that did not appear to be the result of a direct
miRNA-like interaction. Such off-targets included genes that
were annotated as immune response genes, which in the
case of STAT3-1676 appeared to be independent of STAT3
silencing.
2) Although we confirmed that the 29-O-methyl ribosyl
modification at position 2 reduced the number of off-targets
for one of our two siRNA, several off-targets still existed
when cells were treated with a relatively high dose of
modified siRNA. Here, the down-regulated off-targets
included both transcripts that were complementary to the
seed region of the siRNA and transcripts that lacked seed
complementarity. Similar to unmodified siRNA, these off-
targets were significantly reduced at lower effective doses.
3) Increasing the dose from 10 nM to 25 nM not only caused
an increase in the number of down-regulated off-targets that
possess 39UTR complementarity to the seed region, but led
to an even more dramatic increase in the number of off-
targets that lack 39UTR complementarity. For example, in
HK2-3581 the percentage of 2-fold down-regulated off-
targets that possessed seed complementarity in the 39UTR
was 57% at 10 nM and 39% at 25 nM due to a greater
increase in the number of off-targets that were not
complementary to the seed region at 25 nM (Table 2). A
similar trend was observed for STAT3-1676 and STAT3-
1676M, and along these lines, k-mer enrichment analysis
was usually most striking at 10 nM.
Figure 5. Caspase activity and inhibition of cell proliferation. A)
Caspase assays were performed after treating Hep3B cells with 6 pM,
31 pM, 63 pM, 125 pM, 250 pM, 500 pM, 1 nM, 5 nM, 10 nM, and
25 nM of each siRNA. B) Cell proliferation assay were performed for
Hep3B cells after treatment with the same concentrations of each
siRNA.
doi:10.1371/journal.pone.0021503.g005
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treated with a relatively high dose (25 nM) of HK2-3581.
The moderate induction of apoptosis at the higher dose was
also consistent with the increasing number of off-targets
observed at increasing doses. Furthermore, the number of
off-targets observed for HK2-3581 was much larger than the
number of off-targets for other siRNA that targeted HK2.
As discussed below, most siRNA screens are performed at
concentrations that exceed 25 nM.
While the above findings should not be generalized for all
siRNA and their targets, we and others [36] propose that off-
targets are best offset using a modified siRNA at the lowest
possible dose. Obviously, a siRNA must have a high affinity for its
intended target if it is to be effective at a low dose. In contrast, its
seed sequence should not bind 39UTR sequences with high affinity
or at least not to 39UTRs that are amendable to miRNA-like
regulation. Determining which seed sequences meet this criteria
may not be straightforward but could help design more specific
siRNA. While it seems reasonable to avoid seed sequences that are
found in endogenous miRNA, it is also worth noting that the
presence of a miRNA binding site may be dependent on 39UTR
length and the state of the cells [36].
The concentration of siRNA for most genome-wide and
biological screens typically ranges from 25 nM to 100 nM, which
is considerably higher than the doses used in this study. Although
these high doses improve the sensitivity of a screen, they are likely
to increase the number of off-targets. This underscores the need to
validate genes detected in genome-wide screens by using
additional siRNA molecules that target the same gene.
Our discovery that HK2-3581 induced caspase activity
independent of HK2 silencing was serendipitous. Predicting
whether observed off-targets induce a significant phenotypic effect
is not a trivial problem. Here, the majority of the off-targets were
not complementary to the seed region of HK2-3581, and this
expression signature might indicate an unanticipated phenotypic
effect for a given siRNA. Under this premise, we would expect
many of the off-targets to be involved in a common biological
process. Indeed, this was the case for HK2-3581, where the up-
regulated off-targets were enriched in genes involved in the
regulation of cell cycle and were presumably related to the
induction of caspase activity. Nevertheless, the prediction of
phenotypic effects from a set of observed off-targets remains a
difficult problem that warrants further investigation. We eagerly
await the development of such methodologies.
In conclusion, siRNA off-targets alter the expression of many
genes and have the potential to cause undesirable phenotypic
effects. This work demonstrates that is possible reduce and
sometimes eliminate off-target effects for both unmodified siRNA
and 29-O-methyl ribosyl modified siRNA, when cells are treated
with a relatively low dose of siRNA that is still sufficient to
effectively silence the intended target.
Materials and Methods
siRNA
The non-targeting control siRNA (siGenome2) and PLK1
siRNA were purchased from Dharmacon/Thermo Scientific Inc.
The AllStars negative control was purchased from QIAGEN. The
siRNAs that targeted hexokinase II (HK2) and STAT3 were
designed to have minimal complementarity with other transcripts
encoded by the human genome and were synthesized by
Integrated DNA Technologies. The siRNA sequences are
described in Table 1.
Cell culture and transfections
MCF-7 breast cancer cells (American Type Culture Collec-
tion) were grown in Gibco RPMI-1640 (Life Technologies)
supplemented with 10% fetal calf serum and penicillin/strepto-
mycin. Hep3B cells (American Type Culture Collection) were
grown in EMEM (ATCC) supplemented with 10% fetal calf
serum. Cells were maintained in monolayer cultures at 37uCi na n
incubator with 5% CO2. One day prior to transfection, cells were
seeded at 1.6610
5 cells per well in 6 well plates (Real-time PCR
and microarrays) and 4610
3 cells per well in 96 well plates
(Caspase and proliferation assays). Cells were transfected at 30–
60% confluence, using Lipofectamine
TM RNAiMAX (Life Tech-
nologies) according to the manufacturer’s instructions and the
indicated doses of each siRNA.
Unless otherwise stated, cells were transfected with 0, 1 nM,
10 nM, and 25 nM of siRNA. Given that transfection efficiencies
can vary according to the ratio of nucleotide to transfection
reagent, each dose was supplemented with non-targeting (negative)
control siRNA, such that the total RNA concentration was equal
across experiments. For example, in the microarray experiment
where the concentrations of STAT3-1676 were 0, 1 nM, 10 nM,
and 25 nM, we added 25 nM, 24 nM, 15 nM, and 0 nM of
siGenome2 respectively. RNA was purified 48 hours post-
transfection using the RNeasy mini kit from Qiagen.
Real-time PCR
Three biological replicates were used to assess silencing of the
intended targets by real-time PCR. Primers for STAT3 and HK2
were obtained from Applied Biosystems (TaqManH Gene
Expression Assays). Real-time PCR was performed in a total
volume of 25 mL, using the Universal PCR Master Mix as
described in the manufacturers protocol. Relative mRNA levels
were calculated as 2
2DDCt values.
Microarray experiments and computational analysis
Off-targets were assessed using the Affymetrix gene expression
platform and all data is MIAME compliant and available at GEO
(GSE28786). Biological triplicates were used unless specifically
stated. RNA was hybridized to Affymetrix human genome U133
plus 2.0 arrays. The arrays were scanned using an Affymetrix
GeneChip Scanner 3000. Probesets were mapped to Entrez Gene
IDs using custom CDF files [37]. Affymetrix CEL files were
normalized in Bioconductor [38] using the RMA method [39].
Differentially regulated genes were identified using a moderated t-
test [40]. False discovery rate adjusted P-values were calculated
using the method of Benjamini and Hochberg [41]. Genes were
mapped to GO terms using the AnnotationDbi package and GO
enrichment analysis was performed usingthe GOstats package [42].
The longest 39UTR sequence for each human gene was retrieved
using the ENSEMBL API [43] and k-mer enrichment analysis was
performed using an implementation of the Sylamer method [26].
Cell proliferation assays
On assay day, 10 ml of CellTiter-Fluor reagent mix (Promega,
cat#G6081) was added to each well on cell plates. After briefly
shaking at gentle speed, plates were incubated at 37uC for 30 min
before fluorescence signals were measured using a SpectraMax
M5 Microplate Reader(Molecular Devices, CA) at 390ex/505em
with autocutoff =495. Fluorescence data were recorded for cell
proliferation analysis. Linearity of the CellTiter-Fluor assay with
cell number was tested routinely in each experiment and used for
getting a conversion formula of fluorescence signals for calculating
the relative cell numbers.
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Within 1 hour of completing the CellTiter-Fluor assay for cell
proliferation, 96 ml of Caspase3/7 reagent mix (Promega,
cat#G8091) was added to each well of the cell plates. Plates were
shaken gently at room temperature for 1 hr before reading of
luminescence signals (caspase activity) with an Envision plate
reader.
Supporting Information
Figure S1 Off-targets for STAT3-1676. A) Cells were
transfected with 25 nM of siRNA and a relatively large number
of off-targets were detected. B) Cells were transfected with 10 nM
of siRNA and only one of the off-targets was down-regulated more
than the intended target. C) Cells were transfected with 1 nM of
siRNA and none of the off-targets were down-regulated more than
the intended target. Off-targets are defined as transcripts with a 2-
fold change in mRNA levels for one or more concentrations. The
entire set of off-targets are plotted at each concentration. The
volcano plots consist of Log2 fold-change values between control
siRNA and STAT3-1676 on the x-axis and log10 P-values from
the moderated T-test on the y-axis. Off-targets that possess
39UTRs that are complementary to the seed region (position 2–6
of the siRNA) are indicated with a blue diamond. Immune
response genes are indicated with a red circle. Other off-targets
and the intended target are indicated according to the legend.
(EPS)
Figure S2 Off-targets for HK2-3581. A) Cells were trans-
fected with 25 nM of siRNA and a relatively large number of off-
targets were detected. B) Cells were transfected with 10 nM of
siRNA and only one off-target was down-regulated more than the
intended target. C) Cells were transfected with 1 nM of siRNA
and none of the off-targets were down-regulated more than the
intended target. Off-targets are plotted as described in Figure S1.
(EPS)
Figure S3 Off-targets for modified STAT3-1676M. A)
Cells were transfected with 25 nM of siRNA and a relatively large
number of off-targets were detected. B) Cells were transfected with
10 nM of siRNA and only one off-target was down-regulated
more than the intended target. C) Cells were transfected with
1 nM of siRNA and none of the off-targets were down-regulated
more than the intended target. Off-targets are plotted as described
in Figure S1.
(EPS)
Figure S4 Off-targets for modified HK2-3581M. A) Cells
were transfected with 25 nM of siRNA and a large number of off-
targets were detected. B) Cells were transfected with 10 nM of
siRNA and none of the off-targets were down-regulated more than
the intended target. C) Cells were transfected with 1 nM of siRNA
and only one of the off-targets was down-regulated more than the
intended target. Off-targets are plotted as described in Figure S1.
(EPS)
Figure S5 39UTR hexamer enrichment analysis for
STAT3-1676. A) 25 nM. B) 10 nM. C) 1 nM. Transcripts from
each microarray were rank-ordered by log2 fold-change and P-
values were computed at different levels of fold-change (increments
of 100). The hyper-geometric test was used to assess whether a
particular hexamer was over or under-represented in 39UTRs at
each level of fold-change.
(TIF)
Figure S6 39UTR heptamer enrichment analysis for
STAT3-1676. A) 25 nM. B) 10 nM. C) 1 nM. Transcripts from
each microarray were rank-ordered by log2 fold-change and P-
values were computed at different levels of fold-change (increments
of 100). The hyper-geometric test was used to assess whether a
particular heptamer was over or under-represented in 39UTRs at
each level of fold-change.
(TIF)
Figure S7 39UTR hexamer enrichment analysis for
STAT3-1676M. A) 25 nM. B) 10 nM. C) 1 nM. Transcripts
from each microarray were rank-ordered by log2 fold-change and
P-values were computed at different levels of fold-change
(increments of 100). The hyper-geometric test was used to assess
whether a particular hexamer was over or under-represented in
39UTRs at each level of fold-change.
(TIF)
Figure S8 39UTR heptamer enrichment analysis for
STAT3-1676M. A) 25 nM. B) 10 nM. C) 1 nM. Transcripts
from each microarray were rank-ordered by log2 fold-change and
P-values were computed at different levels of fold-change
(increments of 100). The hyper-geometric test was used to assess
whether a particular heptamer was over or under-represented in
39UTRs at each level of fold-change.
(TIF)
Figure S9 39UTR hexamer enrichment analysis for
HK2-3581. A) 25 nM. B) 10 nM. C) 1 nM. Transcripts from
each microarray were rank-ordered by log2 fold-change and P-
values were computed at different levels of fold-change (increments
of 100). The hyper-geometric test was used to assess whether a
particular hexamer was over or under-represented in 39UTRs at
each level of fold-change.
(TIF)
Figure S10 39UTR heptamer enrichment analysis for
HK2-3581. A) 25 nM. B) 10 nM. C) 1 nM. Transcripts from
each microarray were rank-ordered by log2 fold-change and P-
values were computed at different levels of fold-change (increments
of 100). The hyper-geometric test was used to assess whether a
particular heptamer was over or under-represented in 39UTRs at
each level of fold-change.
(TIF)
Figure S11 39UTR hexamer enrichment analysis for
HK2-3581M. A) 25 nM. B) 10 nM. C) 1 nM. Transcripts from
each microarray were rank-ordered by log2 fold-change and P-
values were computed at different levels of fold-change (increments
of 100). The hyper-geometric test was used to assess whether a
particular hexamer was over or under-represented in 39UTRs at
each level of fold-change.
(TIF)
Figure S12 39UTR heptamer enrichment analysis for
HK2-3581M. A) 25 nM. B) 10 nM. C) 1 nM. Transcripts from
each microarray were rank-ordered by log2 fold-change and P-
values were computed at different levels of fold-change (increments
of 100). The hyper-geometric test was used to assess whether a
particular heptamer was over or under-represented in 39UTRs at
each level of fold-change.
(TIF)
Figure S13 Off-targets for HK2-4031. A) Cells were
transfected with 10 nM of HK2-4031 and 0 nM of AllStars
negative control. B) Cells were transfected with 1 nM of HK2-
4031 and 9 nM of AllStars negative control. Off-targets are
defined as transcripts with a 2-fold change in mRNA levels for one
or more concentrations. The entire set of off-targets are plotted at
each concentration. The volcano plots consist of Log2 fold-change
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P-values from the moderated T-test on the y-axis. Off-targets that
possess 39UTRs that are complementary to the seed region
(position 2–6 of the siRNA) are indicated with a blue diamond.
Other off-targets and the intended target are indicated according
to the legend.
(EPS)
Table S1 STAT3-1676 off-targets that are involved in
immune response.
(DOC)
Table S2 Enrichment of STAT3-1676 off-targets that are
involved in immune response.
(DOC)
Table S3 HK2-3581 off-targets that are involved in
immune response.
(DOC)
Table S4 Enrichment of HK2-3581 off-targets that are
involved in cell cycle.
(DOC)
Table S5 HK2-3581 off-targets that are involved in cell
cycle.
(DOC)
Table S6 Enrichment of HK2-3581M off-targets that are
involved in cell cycle.
(DOC)
Table S7 HK2-3581M off-targets that are involved in
cell cycle.
(DOC)
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